Friday, July 10, 2026

Drug profile · INN

human fibrinogen

human fibrinogen (TACHOSIL) is a fibrinogen exogenous protein. Associated with S.A..

EMA: approved Blood and blood forming organs (B02) B02BC30
Patents linked 0
Pipeline programs 7
News articles 0
Drug details — human fibrinogen
Class
Blood and blood forming organs (B02)
Route
Patents
0
Programs
7
Data quality
0.89

Quick answer

human fibrinogen (TACHOSIL) is a fibrinogen exogenous protein. Associated with S.A..

Key facts

INN human fibrinogen
Brand TACHOSIL
Mechanism Fibrinogen exogenous protein
Target Fibrinogen
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BC30
Originator S.A.

Mechanism of action

Fibrinogen exogenous protein

Primary target: Fibrinogen

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. Fibrinogen (human) + thrombin (human) (TachoSil) Phase 3 · Takeda · Surgical Resection of Superficial Renal Tumour
  2. TachoSil® Phase 3 · Takeda · Hemorrhage
  3. TachoSil® Phase 3 · Takeda · Bleeding
  4. TachoSil® Phase 3 · Takeda · Cerebrospinal Fluid Leaks
  5. ALL3024 Phase 2 · Telethon Foundation · Very High-Risk T-Lineage Acute Lymphoblastic Leukemia (ALL)
  6. EC/2013/472 Approved · Takeda · Prostate or Bladder Cancer
  7. TACHOSIL GROUP Approved · Takeda · Lymphocele

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is human fibrinogen?

human fibrinogen (TACHOSIL) is a fibrinogen exogenous protein. Associated with S.A..

What is the brand name for human fibrinogen?

TACHOSIL is a marketed brand name for human fibrinogen. Check FDA Drugs@FDA for the current US label holder and prescribing information.